Skip to main content
. 2019 Feb 16;6(1):26. doi: 10.3390/medicines6010026

Figure 2.

Figure 2

The evaluation process for estimating the clinical significance of a drug interaction between drug A and another medicinal product (drug B or HMP) according to FDA (based on Ref. [47]).